Plain-language guides to the compounds people are talking about. What each one is, how it works, what the science actually shows, and where it stands with regulators.
The gold standard. Beat semaglutide head-to-head by 47% in 2025. Fully approved with the largest weight-loss trial data in the field.
The only FDA-approved GHRH peptide. Targets deep abdominal fat with strong phase 3 trial data behind it.
Phase 3 data shows 30% average weight loss at two years. Approaching bariatric surgery results. Not yet approved.
Supplements reliably raise NAD+ levels that fall with age. Promising research on energy, aging and metabolic health.
The best-evidenced compound here for skin. Controlled trials show measurable collagen and firmness gains.
Your body makes it and levels decline with age. Promising animal data for metabolism and exercise capacity.
Genuine phase 2/3 human trial data across multiple conditions. More rigorously tested than most research peptides.
Extensive animal evidence for accelerated tissue repair. The most popular recovery peptide stack in research.
Targets the biological clock at chromosome level. Compelling cell and animal data on telomere extension.
A targeted NF-kB blocker with strong cell evidence for gut, skin and wound inflammation.
Two complementary peptides working through separate receptors to produce superior GH pulses versus either alone.
The cleanest GH secretagogue in research. Raises GH selectively without cortisol or prolactin side effects.
30+ years of Russian clinical use for cognitive and neuroprotective applications. Intranasal for fast brain access.
Each page tells you exactly where a compound stands — approved, in trials, or research-only — and explains the evidence in plain English rather than jargon. Start with About Peptides if the terms are new to you, or go straight to whichever compound you are curious about. Have a question? Get in touch.